{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T10:42:16Z","timestamp":1793270536905,"version":"4.5.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.ygyno.2013.06.020","type":"journal-article","created":{"date-parts":[[2013,6,20]],"date-time":"2013-06-20T05:02:19Z","timestamp":1371704539000},"page":"36-41","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"title":["Ovarian cancer patients with localized relapse: Clinical outcome and prognostic factors"],"prefix":"10.1016","volume":"131","author":[{"given":"M.","family":"Petrillo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Fagotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Ferrandina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Fanfani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Costantini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Vizzielli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Pedone Anchora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Nero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.A.","family":"Margariti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Scambia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2013.06.020_bb0005","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3322\/caac.21166","article-title":"Cancer statistics, 2013","volume":"63","author":"Siegel","year":"2013","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ygyno.2013.06.020_bb0010","doi-asserted-by":"crossref","first-page":"S161","DOI":"10.1016\/S0020-7292(06)60033-7","article-title":"FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer","volume":"95","author":"Heintz","year":"2006","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.ygyno.2013.06.020_bb0015","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1200\/JCO.1991.9.3.389","article-title":"Second-line platinum therapy in patients with ovarian cancer previously treated with cisplatin","volume":"9","author":"Markman","year":"1991","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ygyno.2013.06.020_bb0020","doi-asserted-by":"crossref","first-page":"3120","DOI":"10.1200\/JCO.2004.05.195","article-title":"Duration of response to second-line, platinum-based chemotherapy for ovarian cancer: implications for patient management and clinical trial design","volume":"22","author":"Markman","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ygyno.2013.06.020_bb0025","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1023\/A:1008240421028","article-title":"Predictors of response to subsequent chemotherapy in platinum pretreated ovarian cancer: a multivariate analysis of 704 patients [see comments]","volume":"8","author":"Eisenhauer","year":"1997","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ygyno.2013.06.020_bb0030","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1525-1438.1991.tb00041.x","article-title":"The \u2018failure free interval' defines the likelihood of resistance to carboplatin in patients with advanced epithelial ovarian cancer previously treated with cisplatin: relevance to therapy and new drug testing","volume":"1","author":"Hoskin","year":"1991","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ygyno.2013.06.020_bb0035","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1016\/j.ejca.2006.03.025","article-title":"Impact of pattern of recurrence on clinical outcome of ovarian cancer patients: clinical considerations","volume":"42","author":"Ferrandina","year":"2006","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ygyno.2013.06.020_bb0040","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/bjc.2011.364","article-title":"Prognostic nomogram to predict progression-free survival in patients with platinum-sensitive recurrent ovarian cancer","volume":"105","author":"Lee","year":"2011","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ygyno.2013.06.020_bb0045","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1093\/annonc\/mds538","article-title":"A prognostic nomogram to predict overall survival in patients with platinum-sensitive recurrent ovarian cancer","volume":"24","author":"Lee","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ygyno.2013.06.020_bb0050","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/IGC.0b013e318286665b","article-title":"Prognostic factors and clinical outcome of patients with recurrent early-stage epithelial ovarian cancer: an Italian multicenter retrospective study","volume":"23","author":"Gadducci","year":"2013","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ygyno.2013.06.020_bb0055","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1186\/1471-2407-8-367","article-title":"Epithelial ovarian cancer relapsing as isolated lymph node disease: natural history and clinical outcome","volume":"8","author":"Legge","year":"2008","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ygyno.2013.06.020_bb0060","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ygyno.2006.06.039","article-title":"Isolated lymph node relapse of epithelial ovarian carcinoma: outcomes and prognostic factors","volume":"104","author":"Blanchard","year":"2007","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2013.06.020_bb0065","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.ygyno.2006.10.020","article-title":"Secondary cytoreductive surgery for isolated nodal recurrence in patients with epithelial ovarian cancer","volume":"104","author":"Santillan","year":"2007","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2013.06.020_bb0070","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1245\/ASO.2004.11.023","article-title":"Outcomes after combined therapy including surgical resection in patients with epithelial ovarian cancer recurrence(s) exclusively in lymph nodes","volume":"11","author":"Uzan","year":"2004","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ygyno.2013.06.020_bb0075","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/cncr.22447","article-title":"Secondary cytoreductive surgery for localized, recurrent epithelial ovarian cancer: analysis of prognostic factors and survival outcome","volume":"109","author":"Salani","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2013.06.020_bb0080","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Non parametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"Am J Stat Assoc"},{"key":"10.1016\/j.ygyno.2013.06.020_bb0085","first-page":"163","article-title":"Evaluation of survival data and two new rank order statistics arising in its consideration","volume":"50","author":"Mantel","year":"1966","journal-title":"Cancer Chemother Rep"},{"key":"10.1016\/j.ygyno.2013.06.020_bb0090","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life tables","volume":"34","author":"Cox","year":"1972","journal-title":"J R Stat Soc"},{"key":"10.1016\/j.ygyno.2013.06.020_bb0095","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S1470-2045(06)70939-1","article-title":"Mechanisms of transcoelomic metastasis in ovarian cancer","volume":"7","author":"Tan","year":"2006","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ygyno.2013.06.020_bb0100","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1111\/j.1525-1438.2006.00660.x","article-title":"Identification of genes associated with ovarian cancer metastasis using microarray expression analysis","volume":"16","author":"Lancaster","year":"2006","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ygyno.2013.06.020_bb0105","doi-asserted-by":"crossref","first-page":"245.e1","DOI":"10.1016\/j.ajog.2006.10.874","article-title":"Gene expression profile of ovarian serous papillary carcinomas: identification of metastasis-associated genes","volume":"196","author":"Bignotti","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2013.06.020_bb0110","first-page":"CD007822","article-title":"Cytoreductive surgery plus chemotherapy versus chemotherapy alone for recurrent epithelial ovarian cancer","author":"Galaal","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ygyno.2013.06.020_bb0115","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1002\/cncr.21845","article-title":"Guidelines and selection criteria for secondary cytoreductive surgery in patients with recurrent, platinum-sensitive epithelial ovarian carcinoma","volume":"106","author":"Chi","year":"2006","journal-title":"Cancer"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825813008536?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825813008536?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,12]],"date-time":"2024-05-12T17:08:21Z","timestamp":1715533701000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825813008536"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S0090825813008536"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2013.06.020","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ovarian cancer patients with localized relapse: Clinical outcome and prognostic factors","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2013.06.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}